ANXA7-GTPase as tumor suppressor: Mechanisms and therapeutic opportunities

Methods in Molecular Biology

Volumn 1513, Issue , 2017, Pages 23-35

  Leighton, Ximena ^a   Eidelman, Ofer ^a   Jozwik, Catherine ^a   Pollard, Harvey B ^a   Srivastava, Meera ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

ANXA7 GTPase; Apoptosis; Calcium; Cancer; Tumor suppressor gene

Indexed keywords

CALCIUM; GUANOSINE TRIPHOSPHATASE; SYNEXIN; TUMOR SUPPRESSOR PROTEIN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

APOPTOSIS; CALCIUM BINDING; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CANCER DIAGNOSIS; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 10Q21; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; KNOCKOUT MOUSE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DIAGNOSIS; NONHUMAN; PROTEIN FUNCTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; AGONISTS; BREAST TUMOR; CHROMOSOME 10; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; HETEROZYGOSITY LOSS; KIDNEY TUMOR; MALE; METABOLISM; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; SIGNAL TRANSDUCTION; THERAPEUTIC USE;

ANNEXIN A7; BREAST NEOPLASMS; CALCIUM; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; GENETIC VECTORS; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; PROSTATIC NEOPLASMS; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 84994213346     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6539-7_3     Document Type: Chapter

References (66)

1. Shen WP, Young RF, Walter BN et al (1990) Molecular analysis of a myxoid chondrosarcoma with rearrangements of chromosomes 10 and 22. Cancer Genet Cytogenet 45: 207-215
2. Jenkins RB, Hay ID, Herath JF et al (1990) Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 66:1213-1220
3. Morita R, Saito S, Ishikawa J et al (1991) Common regions of deletion on chromosomes 5q, 6q and 10q in renal cell carcinoma. Cancer Res 51:5817-5820
4. Shah NK, Wagner J, Santos G, Griffin CA (1992) Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia. Cancer Genet Cytogenet 61:183-192
5. Oberstrass J, Ring GU, Vogeley KT et al (1994) Allelieuntersuchungen auf Chomosom 10q21-26 in malignen Gliomen. Verh Dtsch Ges Pathol 78:413-417
6. Steck PA, Lignon AH, Cheong P et al (1995) Two tumor suppressive loci on chromosome 10 involved in human glioblastoma. Genes Chromosomes Cancer 12:255-261
7. Solic N, Collins JE, Richter A et al (1995) Two newly established cell lines derived from the same colonic adenocarcinoma exhibit differences in EGF-receptor ligand and adhesion molecule expression. Int J Cancer 62:48-57
8. Petersen S, Wolf G, Bockmuhl U et al (1998) Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br J Cancer 77:270-276
9. Piao Z, Park C, Park JH, Kim H (1998) Allotype analysis of hepatocellular carcinoma. Int J Cancer 75:29-33
10. Lacombe L, Orlow I, Reuter VE et al (1996) Microsatellite instability and deletion analysis of chromosome 10 in human prostate cancer. Int J Cancer 69:110-113
11. Li J, Yen C, Liaw D et al (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947
12. Maier D, Zhang Z, Taylor E et al (1998) Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low grade and high grade gliomas. Oncogene 16:3331-3335
13. Srivastava M, Bubendorf L, Nolan L et al (2001) ANXA7, a candidate tumor-suppressor gene for prostate cancer. Proc Natl Acad Sci U S A 98:4575-4578
14. Leighton X, Srikantan V, Pollard HB et al (2004) Significant allelic loss of ANXA7 region (10q21) in hormone receptor negative breast carcinomas. Can Lett 210:239-244
15. Klee CB (1988) Ca2+-dependent phospholipid-(and membrane-)binding proteins. Biochemistry 27:6645-6653
16. Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium-and phospholipid-binding proteins. BBA Biomembranes 1197:63-93
17. Smith PD, Moss SE (1994) Structural evolution of the annexin supergene family. Trends Genet 10:241-246
18. Flower RJ, Rothwell NJ (1994) Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15:71-76
19. McKanna JA (1995) Lipocortin 1 in apoptosis: mammary regression. Anat Rec 242:1-10
20. Rothhut B (1997) Participation of annexins in protein phosphorylation. Cell Mol Life Sci 53:522-526
21. Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331-371
22. Pollard HB, Rojas E (1988) Calcium acivated ANXA7 forms highly selective, voltage-gated channels in phosphatidylserine bilayer membranes. Proc Natl Acad Sci U S A 85: 2974-2978
23. Kubista H, Hawkins TE, Patel DR et al (1999) Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells. Curr Biol 9:1403-1406
24. Paweletz CP, Ornstein DK, Roth MJ et al (2000) Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res 60:6293-6297
25. Chetcuti A, Margan SH, Russell P et al (2001) Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 61:6331-6334
26. Kang JS, Calvo BF, Maygarden SJ et al (2002) Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res 8:117-123
27. Xin W, Rhodes DR, Ingold C et al (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162:255-261
28. Smitherman AB, Mohler JL, Maygarden SJ, Ornstein DK (2004) Expression of annexin I, II and VII proteins in androgen stimulated and recurrent prostate cancer. J Urol 171:916-920
29. Yadav AK, Renfrow JJ, Scholtens DM (2009) Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas. JAMA 302:276-289
30. Bredel M, Scholtens DM, Harsh GR (2009) A network model of a cooperative genetic landscape in brain tumors. JAMA 302:261-275
31. Kataoka TR, Ito A, Asada H (2000) Annexin VII as a novel marker for invasive phenotype of malignant melanoma. Jpn J Cancer Res 91:75-83
32. Shirvan A, Srivastava M, Wang MG et al (1994) Divergent Structure of the human ANXA7 (annexin VII) gene and assignment to chromosome 10. Biochemistry 33:6888-6901
33. Zhang-Keck Z-Y, Burns AL, Pollard HB (1993) Mouse ANXA7 (annexin VII) polymorphisms and phylogenetic comparison with other ANXA7s. Biochem J 289:735-741
34. Zhang-Keck Z-Y, Srivastava M, Kozak CA et al (1994) Genomic organization and chromosomal localization of the mouse ANXA7 (annexin VII) gene. Biochem J 301:835-845
35. Srivastava M, Zhang-Keck ZY, Caohuy H et al (1996) Novel isoforms of ANXA7 in Xenopus laevis : multiple tandem PGQM repeats distinguish mRNA’s in specific adult tissues and embryonic stages. Biochem J 316:729-736
36. Doring V, Schleicher M, Noegel AA (1991) Dictyostelium annexin VII (ANXA7). J Biol Chem 266:17509-17515
37. Gerke V (1991) Identification of a homologue for annexin VII (synexin) in Dictyostelium discoideum. J Biol Chem 266:1697-1700
38. Sun M-Z, Liu S, Tang J (2009) Targeting annexin A7 in hepatocarcinoma lymphatic metastasis. Chin J Lung Cancer 12:633-634
39. Gong X, Tang J, Geng X (2009) Expression and significance of Annex in A7 in gastric cancer and lymphatic metastasis. Int J Pathol Clin Med 29:369-373
40. Yang M, Liang Q (2011) Study the relationship between the expression of Annexin A7 and CT of nasopharyngeal carcinoma. J Chin Clin Med Imaging 22:6-9
41. Jimenez CR, Knol JC, Meijer GA (2010) Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics 73:1873-1895
42. Srivastava M, Torosyan Y, Raffeld M (2007) ANXA7 expression represents hormonerelevant tumor suppression in different cancers. Int J Cancer 121:2628-2636
43. Guo C, Liu S, Greenway F, Sun M-Z (2013) Potential role of annexin A7 in cancers. Clin Chim Acta 423:83-89
44. Srivastava M, Bubendorf L, Raffeld M et al (2004) Prognostic impact of ANXA7-GTPase in metastatic and HER2 negative breast cancer patients. Clin Cancer Res 7:2344-2350
45. Srivastava M, Bubendorf L, Nolan L et al (2001) ANXA7 as a biomarker in prostate and breast cancer progression. Dis Markers 17:115-120
46. Bubendorf L, Sauter G, Moch H et al (1996) Prognostic significance of Bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557-1565
47. Silvestrini R, Veneroni S, Daidone MG et al (1994) The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504
48. Villar E, Redondo M, Rodrigo I et al (2001) Bcl-2 expression and apoptosis in primary and metastatic breast carcinomas. Tumour Biol 22:137-145
49. Bonkhoff H, Remberger K (1996) Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28: 98-106
50. Li P, Barraclough R, Fernig DG et al (1998) Stem cells in breast epithelia. Int J Exp Pathol 79:193-206
51. Feuerhake F, Sigg W, Höfter EA et al (2000) Immunohistochemical analysis of Bcl-2 and Bax expression in relation to cell turnover and epithelial differentiation markers in the nonlactating human mammary gland epithelium. Cell Tissue Res 299:47-58
52. Srivastava M, Montagna C, Leighton X et al (2003) Haploinsufficiency of ANXA7 tumor suppressor gene and consequent genomic instability promotes tumorigenesis in the ANXA7(+/−) mouse. Proc Natl Acad Sci U S A 100:14287-14292
53. Srivastava M, Atwater I, Glasman M et al (1999) Defects in IP 3 receptor expression, Ca 2+-signaling and insulin secretion in the ANXA7 (+/−) knockout mouse. Proc Natl Acad Sci U S A 96:13783-13788
54. Srivastava M, Kumar P, Leighton X et al (2002) Influence of the Anx7 +/− knockout mutation and fasting stress on the genomics of the mouse adrenal gland. Ann N Y Acad Sci 971:53-60
55. Kim T, Tao-Cheng JH, Eiden LE, Loh YP (2002) Large dense-core secretory granule biogenesis is under the control of chromogranin A in neuroendocrine cells. Ann N Y Acad Sci 971:323-331
56. Goping G, Pollard HB, Srivastava M, Leapman R (2003) Mapping protein expression in mouse pancreatic islets by immunolabeling and electron energy loss spectrum-imaging. Microsc Res Tech 61:448-456
57. Srivastava M, Eidelman O, Leighton X et al (2002) ANXA7 is required for nutritional control of gene expression in mouse pancreatic islets of Langerhans. Mol Med 8:781-797
58. Furuya Y, Lundmo P, Short AD et al (1994) The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen independent prostatic cancer cells induced by thapsigargin. Cancer Res 54: 6167-6175
59. Kyprianou N, Bains AK, Jacobs SC (1994) Induction of apoptosis in androgenindependent human prostate cancer cells undergoing thymineless death. Prostate 25: 66-75
60. Wertz IE, Dixit VM (2000) Characterization of calcium release-activated apoptosis of LnCaP prostate cancer cells. J Biol Chem 275:11470-11477
61. Kass GE, Orrenius S (1999) Calcium signaling and cytotoxicity. Environ Health Perspect 107:25-35
62. Scoltock AB, Bortner CD, St J, Bird G et al (2000) A selective requirement for elevated calcium in DNA degradation, but not early events in anti-Fas-induced apoptosis. J Biol Chem 275:30586-30596
63. Lin XS, Denmeade SR, Cisek L, Isaacsm JT (1997) Mechanism and role of growth arrest in programmed (apoptotic) death of prostatic cancer cells induced by thapsigargin. Prostate 33:201-207
64. Tombal B, Weeraratna AT, Denmeade SR, Isaacs JT (2000) Thapsigargin induces a calmodulin/calcineurin-dependent apoptotic cascade responsible for the death of prostatic cancer cells. Prostate 43:303-317
65. Furuya Y, Ohta S, Ito H (1997) Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation. Anticancer Res 17:2089-2093
66. Szalai G, Krishnamurthy R, Hajnóczky G (1999) Apoptosis driven by IP (3)-linked mitochondrial calcium signals. EMBO J 18: 6349-6361